A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
Clinical trial NCT06941142 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06941142
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2027-10-01
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.